Format

Send to

Choose Destination
Curr Treat Options Oncol. 2001 Apr;2(2):119-28.

New drugs in gynecologic cancer.

Author information

1
Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

Abstract

The implementation of new drug treatments has improved the prognosis for advanced cancers of the cervix, uterus, and ovary. Platinum analogs are the most effective drugs in the treatment of ovarian cancer. Other drugs, such as oxaliplatin, have been proposed as a rational treatment of platinum refractory ovarian cancer. Epothilones are also being studied in clinical trials, as are histone deacetylase inhibitors. Several promising agents may soon receive Food and Drug Administration approval.

PMID:
12057130
DOI:
10.1007/s11864-001-0054-0
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center